Kuros Biosciences AG KUROS BIOSCI.../ CH0325814116 /
23.05.2024 17:11:52 | Изменение - | Объем сделки | Бид6:00:04 | Предложение6:00:04 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
7.970CHF | - | 520 Оборот: 4,135.590 |
-Величина цены спроса: - | -Величина цены предложения: - | 414.61 млнCHF | - | - |
GlobeNewswire
11:00
Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
GlobeNewswire
11:00
VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery C...
GlobeNewswire
11:00
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Tr...
GlobeNewswire
10:00
Master the Complexities of International Mergers & Acquisitions with IBFD's New Online Course!
GlobeNewswire
10:00
SiSaf’s Bio-Courier Technology Enables Clinical Trial Success for Topical Treatment of Mild to Moder...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
10:00
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black ...
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница